PipelineReview.com20 小时
Algiax Announces Positive Data from Phase 2a Proof of Concept Study Evaluating AP-325 in ...
DÜSSELDORF, Germany I 04, 2025 I Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic ...